MasitinibL shows promise as a drug-like analog of masitinib that elicits comparable SARS-Cov-2 3CLpro inhibition with low kinase preference
SARS-CoV-2 infection has led to several million deaths worldwide and ravaged the
economies of many countries. Hence, developing therapeutics against SARS-CoV-2 …
economies of many countries. Hence, developing therapeutics against SARS-CoV-2 …
Csc01 shows promise as a potential inhibitor of the oncogenic G13D mutant of KRAS: an in silico approach
About 30% of malignant tumors include KRAS mutations, which are frequently required for
the development and maintenance of malignancies. KRAS is now a top-priority cancer target …
the development and maintenance of malignancies. KRAS is now a top-priority cancer target …
Revolutionizing drug discovery: an AI-powered transformation of molecular docking
AA Fadahunsi, HO Uzoeto, NO Okoro… - Medicinal Chemistry …, 2024 - Springer
AI-based molecular docking, a computational technique fueled by artificial intelligence (AI)
algorithms, is transforming the landscape of drug discovery. This method, crucial for …
algorithms, is transforming the landscape of drug discovery. This method, crucial for …